← Back to catalogue

Vitros

FDA UDI

Class II (US FDA UDI)

by Ortho-Clinical Diagnostics

Identity

Trade Name
VITROS FDA UDI
Generic Name
Cancer antigen 19-9 (CA19-9) IVD, kit, chemiluminescent immunoassay FDA UDI
Device Name
VITROS Immunodiagnostic Products CA 19-9 Reagent Pack FDA UDI
Model / Reference
6802241 FDA UDI
Description
VITROS Immunodiagnostic Products CA 19-9 Reagent Pack FDA UDI

Identifiers

Catalog Number
6802241 FDA UDI
Primary DI / UDI-DI
10758750002351 FDA UDI
FDA Product Code
NIG FDA UDI
GMDN Term
Cancer antigen 19-9 (CA19-9) IVD, kit, chemiluminescent immunoassay FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.6010 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Cancer antigen 19-9 (CA19-9) IVD, kit, chemiluminescent immunoassay

Vitros by Ortho-Clinical Diagnostics — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Cancer antigen 19-9 (CA19-9) IVD, kit, chemiluminescent immunoassay.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Ortho-Clinical Diagnostics

Sources (1)

  • FDA UDI 3dda7961-15f1-430c-ba65-122fd092510f 35 fields · synced May 30, 2026